2.5 ml of semaglutide Drugmakers and pharmacists battle over who gets to make obesity drugs Semaglutide Injection 2.4mg at ₹

Key safety considerations include: Absolute contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) [1] Important warnings and precautions: Not recommended in patients with severe gastroparesis IBS-specific assessment: Dehydration risk increases when gastrointestinal side effects occur, particularly with diarrhea or persistent nausea limiting fluid intake

While tirzepatide has produced greater average weight loss than semaglutide in head-to-head clinical trials, that doesnt mean its the best choice for everyone

May support reduced calorie intake alongside lifestyle changes

The typical injection volume was 200 l